The effects of GLP‐1 RA on chronic inflammatory diseases, including nonalcoholic fatty liver disease and atherosclerosis, are mediated by reduced activity of inflammatory pathways, which may affect COVID‐19.56 This evidence concerns the gene GLP1R and atherosclerosis.